Aflac Incorporated Announces Fourth Quarter Earnings Release
Aflac Incorporated (NYSE: AFL) has announced an important update for investors. The company is set to release its financial results for the fourth quarter of 2024 after the market closes. This event is anticipated for early February, marking a crucial moment in analyzing the company's performance over the past year.
Details of the Financial Results Release
On February 5, 2025, Aflac will provide access to earnings materials that will detail their quarterly financial performance. Investors will find the earnings release and financial supplement available on their official Investor Relations website. Alongside these materials, a financial update video featuring Max Brodén, the Senior Executive Vice President and Chief Financial Officer, will be presented, providing further insights into the company’s fiscal health.
Webcast and Conference Call Information
The following day, February 6, at 8:00 a.m. (ET), Aflac is scheduled to host a live conference call to discuss these results in depth. During this webcast, Aflac's Chairman and CEO, Daniel P. Amos, along with Brodén and Virgil Miller, the President of Aflac Incorporated and Aflac U.S., will share their insights on the performance metrics. This discussion will also address the outlook for the upcoming period.
How to Access the Webcast
To participate in the conference call, investors are encouraged to register five to seven minutes before the start time. This registration will enable access to valuable discussions and Q&A sessions with executive management from both the U.S. and Japan, ensuring that participants can gain comprehensive insights.
About Aflac Incorporated
Aflac Incorporated, a Fortune 500 company, has a rich history of providing financial protection and peace of mind to millions of policyholders. With a robust presence in both the United States and Japan, Aflac is recognized as the leading provider of supplemental health insurance products in the U.S. and holds a significant role in cancer and medical insurance in Japan through Aflac Life Insurance Japan.
Aflac's Commitment to Its Policyholders
The company's dedication to customer support is reflected in its numerous accolades, including being listed among the World's Most Ethical Companies for 18 consecutive years and Fortune's World's Most Admired Companies for the past 23 years. Aflac is devoted to being there for policyholders when they need assistance, emphasizing its commitment to ethical practices and corporate responsibility.
Investing in the Future
Aflac also made strides in sustainability, becoming a signatory to the Principles for Responsible Investment (PRI) and featuring in the Dow Jones Sustainability North America Index for over a decade. The company’s initiatives aim at ensuring that it not only meets but exceeds the expectations of investors and policyholders alike.
Contact Information for Inquiries
For more information, those interested may contact David A. Young for analyst and investor relations or Ines Gutzmer for media relations. Both contacts can provide further information on Aflac’s activities and commitments.
Frequently Asked Questions
What are the key dates for Aflac's earnings release?
Aflac will release its fourth quarter financial results on February 5, 2025, followed by a conference call on February 6, 2025.
Who will be featured in the conference call?
Daniel P. Amos, Max Brodén, and Virgil Miller, along with members of Aflac's executive management team, will participate in the call.
How can I access the financial materials?
The financial results and materials will be available on Aflac’s Investor Relations website after the earnings release.
What is Aflac's position in the insurance market?
Aflac is the leading provider of supplemental health insurance in the U.S. and holds a prominent position in Japan regarding cancer and medical insurance.
How is Aflac committed to corporate responsibility?
Aflac has received accolades for its ethical practices and has joined global initiatives that promote sustainability and responsible investing.
